MK-7602: a potent multi-stage dual-targeting antimalarial.
Favuzza P, Palandri J, de Lera Ruiz M, Bailey W, Boyce CW, Danziger A, Fawaz MV, Kelly M, Murgolo N, Robbins JA, Vavrek M, Zhao L, Lei Z, Guo Z, Reaksudsan K, Steel RWJ, Hodder AN, Ngo A, Dziekan JM, Thompson JK, Triglia T, Birkinshaw RW, Penington JS, Scally SW, Dans MG, Coyle R, Sevilleno N, Orban A, Feufack-Donfack LB, Popovici J, Lee MCS, Papenfuss A, Lowes KN, Sleebs BE, McCarthy JS, McCauley JA, Boddey JA, Olsen DB, Cowman AF.
Favuzza P, et al. Among authors: cowman af.
EBioMedicine. 2026 Jan;123:106061. doi: 10.1016/j.ebiom.2025.106061. Epub 2025 Dec 6.
EBioMedicine. 2026.
PMID: 41353980
Free PMC article.